Jump to content

Richard Gallo: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Tag: possible unreferenced addition to BLP
Line 29: Line 29:
2023- Van Scott Lectureship and Frost Award, [[American Academy of Dermatology]]
2023- Van Scott Lectureship and Frost Award, [[American Academy of Dermatology]]


2022- Rothman Award, [[Society for Investigative Dermatology]]
2022- Rothman Award, Society for Investigative Dermatology
2022- David Martin Carter Award, American Skin Association
2022- David Martin Carter Award, American Skin Association
Line 43: Line 43:
2014- Elected [[American Society for Microbiology]], Dohi Lecturship and Honorary membership in Japanese Dermatology Association
2014- Elected [[American Society for Microbiology]], Dohi Lecturship and Honorary membership in Japanese Dermatology Association


2013- Rook Oration, [[British Academy of Dermatology]]
2013- Rook Oration, British Academy of Dermatology


2012- Sulzberger Award- American Academy of Dermatology, Lerner lecture-Yale, Gilliam Lecture-UT Southwestern
2012- Sulzberger Award- American Academy of Dermatology, Lerner lecture-Yale, Gilliam Lecture-UT Southwestern


2011- Rene’Touraine Award-[[European Society Dermatologic Research]]
2011- Rene’Touraine Award-European Society Dermatologic Research


2010- Elected [[Association of American Physicians]]
2010- Elected [[Association of American Physicians]]


2009- Stiefel Lectureship, [[Dermatology Foundation]]; Blank Lectureship, SID; Mertz award, Duhring Lectureship-U Penn
2009- Stiefel Lectureship, Dermatology Foundation; Blank Lectureship, SID; Mertz award, Duhring Lectureship-U Penn


2007- CE.R.I.E.S. Award
2007- CE.R.I.E.S. Award


2006- Montagna Award, [[Society for Investigative Dermatology]]
2006- Montagna Award, Society for Investigative Dermatology


2003- Elected [[American Society for Clinical Investigation]]
2003- Elected [[American Society for Clinical Investigation]]

Revision as of 15:28, 5 April 2023

Richard L. Gallo
Born (1958-12-09) December 9, 1958 (age 66)
United States
Occupation(s)Professor, Dermatologist
Known forAntimicrobial Peptides, Microbiome

Richard L. Gallo M.D., Ph.D. is a Distinguished Professor and founding Chairman of Dermatology at the University of California, San Diego. His research accomplishments as a physician-scientist include discovery of antimicrobial peptides in mammalian skin, establishing new links between innate immunity and skin diseases such as atopic dermatitis and rosacea, and defining the functions of the skin microbiome in host immune defense.

Education

Gallo did his undergraduate studies at the University of Chicago, earned his MD and PhD at the University of Rochester, interned in Pediatrics at Johns Hopkins Hospital, was a Dermatology resident at Harvard Medical School and was a postdoctoral fellow at Harvard University under the supervision of Merton Bernfield'

Research

Gallo studies how humans interact with the environment and protect themselves from infection. He discovered that antimicrobial peptides are present in mammalian skin by demonstrating that cathelicidin antimicrobial peptides(Cathelicidins) are present during wound repair.[1] Subsequent work from his laboratory used molecular techniques to produce a knock out mouse that has shown how cathelicidin antimicrobials protect against infection in several organs including the skin.[2] By using a wide variety of biochemical and genetic tools his work has also shown that other antimicrobial peptides and elements of innate immunity such as Toll-like receptors and Hyaluronan influence human health. His work has translated into a new understanding of the cause of rosacea, a finding with immediate therapeutic implications. Most recently his research has defined biochemical mechanisms through which Vitamin D and the normal skin microflora Microbiome can control immune responses. These latest findings have advanced understanding of the Hygiene hypothesis, Atopic Dermatitis and Rosacea. His analysis of the function of the human skin microbiome is leading discovery of new therapeutic approaches to disease by discovering molecules from bacteria on the skin that can be used for drugs.

Several press releases and scientific publications have reported his discoveries.[3][4][5][6][7][8][9][10]

Awards and honors

2023- Van Scott Lectureship and Frost Award, American Academy of Dermatology

2022- Rothman Award, Society for Investigative Dermatology

2022- David Martin Carter Award, American Skin Association

2019- NIH MERIT award

2018- Named Irma Gigli Endowed Chair of Dermatology, UCSD

2017- Elected lected as a fellow of the American Association for the Advancement of Science, Newcomer Lectureship- UCLA, Lifetime Achievement Award- Manchester UK

2015- Haynes Lectureship, Harvard Medical School, Rodan-Fields Lectureship, Stanford University

2014- Elected American Society for Microbiology, Dohi Lecturship and Honorary membership in Japanese Dermatology Association

2013- Rook Oration, British Academy of Dermatology

2012- Sulzberger Award- American Academy of Dermatology, Lerner lecture-Yale, Gilliam Lecture-UT Southwestern

2011- Rene’Touraine Award-European Society Dermatologic Research

2010- Elected Association of American Physicians

2009- Stiefel Lectureship, Dermatology Foundation; Blank Lectureship, SID; Mertz award, Duhring Lectureship-U Penn

2007- CE.R.I.E.S. Award

2006- Montagna Award, Society for Investigative Dermatology

2003- Elected American Society for Clinical Investigation

2002- Stern Endowment for Dermatology Research, Nobel Lectureship- Karolinska Institute

1990- AMA/Archives of Dermatology Young Investigator Award

References

  1. ^ Gallo RL, Ono M, Povsic T, Page C, Eriksson E, Klagsbrun M, Bernfield M (November 1994). "Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds". Proceedings of the National Academy of Sciences of the United States of America. 91 (23): 11035–9. Bibcode:1994PNAS...9111035G. doi:10.1073/pnas.91.23.11035. PMC 45161. PMID 7972004.
  2. ^ Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL (November 2001). "Innate antimicrobial peptide protects the skin from invasive bacterial infection". Nature. 414 (6862): 454–7. Bibcode:2001Natur.414..454N. doi:10.1038/35106587. PMID 11719807. S2CID 4413198.
  3. ^ "Cause Of Skin Condition Rosacea Discovered". Science Daily. 5 August 2007. Retrieved 29 December 2011.
  4. ^ "Oral Vitamin D May Help Prevent Some Skin Infections". ScienceDaily. October 2008.
  5. ^ "Dirt can be good for children, say scientist". BBC News. November 2009.
  6. ^ Kain D (23 November 2009). "Surface bacteria maintains skin's healthy balance". UC Newsroom. Archived from the original on 15 January 2014.
  7. ^ Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY (October 2002). "Endogenous antimicrobial peptides and skin infections in atopic dermatitis". The New England Journal of Medicine. 347 (15): 1151–60. doi:10.1056/NEJMoa021481. PMID 12374875.
  8. ^ Lai Y, Di Nardo A, Nakatsuji T, Leichtle A, Yang Y, Cogen AL, Wu ZR, Hooper LV, Schmidt RR, von Aulock S, Radek KA, Huang CM, Ryan AF, Gallo RL (December 2009). "Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury". Nature Medicine. 15 (12): 1377–82. doi:10.1038/nm.2062. PMC 2880863. PMID 19966777.
  9. ^ Nakatsuji T, Chen TH, Narala S, Chun KA, Two AM, Yun T, Shafiq F, Kotol PF, Bouslimani A, Melnik AV, Latif H, Kim JN, Lockhart A, Artis K, David G, Taylor P, Streib J, Dorrestein PC, Grier A, Gill SR, Zengler K, Hata TR, Leung DY, Gallo RL (February 2017). "Staphylococcus aureusand are deficient in atopic dermatitis". Science Translational Medicine. 9 (378): eaah4680. doi:10.1126/scitranslmed.aah4680. PMC 5600545. PMID 28228596.
  10. ^ Nakatsuji T, Chen TH, Butcher AM, Trzoss LL, Nam SJ, Shirakawa KT, Zhou W, Oh J, Otto M, Fenical W, Gallo RL (February 2018). "Staphylococcus epidermidisprotects against skin neoplasia". Science Advances. 4 (2): eaao4502. doi:10.1126/sciadv.aao4502. PMC 5834004. PMID 29507878.